After 30 years in the making, gene therapy is finally an FDA-approved reality. What comes next—and how will Crispr get a slice of the action?
There’s been a flurry of research recently trying to pin down a single gene that could be responsible for obesity, but the fact is genes
The most commonly used gene expression profile test, Oncotype DX®, used to help predict breast cancer recurrence may not be as cost-effective as once thought,
Recent advances in gene therapies have been a boon to those researchers investigating the genetic causes of disease. With global obesity levels reaching epidemic proportions
A study demonstrates that a gene therapy approach can lead to the long-term survival of functional beta cells as well as normal blood glucose levels
Researchers have made another discovery at the cellular level to help understand the basic processes of all life on our planet — this time within
A new study has found germline variations in a key tumor suppressor gene that may prompt changes in treatment and follow-up care for certain high-risk
A recently approved gene therapy promising to restore vision in people with a rare genetic disease has just been priced at $ 850,000 per treatment.
Researchers have discovered that a common fusion of two adjacent genes can cause cancer by kicking mitochondria into overdrive, increasing the amount of fuel available
Through gene therapy, researchers engineered blood-forming stem cells (hematopoietic stem/progenitor cells, or HSPCs) to carry chimeric antigen receptor (CAR) genes to make cells that can